This Meeting Takes Place in:
Fast-Track Your mRNA-Based Vaccines & Therapeutics from Discovery to Commercialization by Ensuring Targeted Delivery, Durability & Tolerable Immunogenicity Across All Disease Indications
Welcome to the World’s Largest Industry-Dedicated Gathering for
mRNA Professionals
The world's first non-COVID mRNA approval from Moderna is spurring a new wave of candidates moving into early- to late-stage clinical development for rare, infectious and oncological indications. With tremendous strides in the industry, the 4th mRNA-Based Therapeutics Summit cements its position as the world's largest, end-to-end mRNA conference, bringing you exclusive scientific and strategic insights from the biggest players across indications and modalities.
Access the 3-day, 4-track agenda, 65+ speaker line-up and
pre-conference focus days
A Snapshot of the 65+ Speaker Faculty
"This is an opportunity to better understand the industry’s needs, and explain the FDA’s expectations.”
Peter Marks, Director CBER
What to Expect:
Lead Partner
Industry Partner
Expertise Partners
